期刊文献+

肺结核空洞住院患者结核菌耐药性分析 被引量:3

Analysb of the tuberculosis drug-resistance characteristics of pulmonary tuberculosis with cavitary of hospitalized patients
下载PDF
导出
摘要 目的:探讨肺结核空洞住院患者结核菌耐药性特征。方法:采用BACTEC MGIT快速培养仪做痰结核菌耐药性及药敏试验。结果:肺结核空洞患者总耐药率,耐单药率,耐多药率高于肺结核未出现空洞患者;耐药顺序从高到低依次为:异烟肼(H)、链霉素(S)、利福平(R)、乙胺丁醇(E)。结论:高耐药率,尤其是肺结核空洞患者高耐药率,应引起全社会的重视,寻找一条切实可行的控制耐药结核菌的办法是目前的当务之急。 Objective To investigate the tuberculosis drug - resistance characteristics of tuberculosis with cavitary of hospitalized pa- tients in our city. Method We used rapid culture system with BACTEC MGIT to do sputum drug resistance and sensitivity test. Results ( 1 ) The total resistance rate, single drug resistance rate and emergence of MDR - TB rates were higher in patients with pulmonary tubercu- losis cavity than in patients without cavity; (2) resistance order from high to low was:H, S, R, E. Conclusion High resistance rates of drug resistance tuberculosis,especially in patients with pulmonary tuberculosis cavity, should be payed a attention by the whole society. Looking for a practical way to control drug- resistant tuberculosis is a current priority.
出处 《吉林医学》 CAS 2012年第34期7474-7475,共2页 Jilin Medical Journal
关键词 肺结核 空洞 耐药性 Pulmonary tuberculosis Cavitary Drug resistance
  • 相关文献

参考文献4

二级参考文献33

  • 1阚冠卿,张立兴,屠德华,蒋建英.积极开展结核菌原发耐药性趋势的连续观察[J].中国防痨杂志,1994,16(1):1-2. 被引量:23
  • 2结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 3王陇德.中国结核病控制现状及展望[J].中华结核和呼吸杂志,2006,29(8):505-506. 被引量:121
  • 4张敦熔.耐药性的流行病学意义[J].中国防痨杂志,1997,4:155-155.
  • 5王坤英 徐瑞兴 等.北京市西城区1984年新登活动性肺结核诊断前的查治情况分析[J].中国防痨通讯,1986,8(2):7-9.
  • 6World Health Organization. Guideline for the programmatic management of drug-resistant tuberculosis emergency update 2008 (WHO/HTM/TB/2008.402). Geneva: WHO,2008.
  • 7Raviglione MC, Uplekar MW. WHO ' s new Stop TB Strategy. Lancet, 2006,367: 952-955.
  • 8World health organization. Anti-tuberculosis drug resistance in the world report No. 4 ( WHO/HTM/TB/2008. 394). Geneva: WHO, 2008.
  • 9World Health Organization. Global Tuberculosis Control 2009. Epidcmiology strategy financing ( WHO/HTM/TB/2009. 411). Geneva: WHO,2009.
  • 10World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis (WHO/HTM/TB/ 2006. 361). Geneva: WHO,2006.

共引文献282

同被引文献21

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部